Y-Intercept (HK)’s Generate Biomedicines GENB Stock Holding History

Y-Intercept (HK)’s Portfolio GENB Stock Details GENB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,362	Closed	-$230K	–	2277
2026 Q1	$230K	Buy	+18,362	New	+$224K	﹤0.01%	1426

Other funds holding GENB

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

AFG

Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Y-Intercept (HK)'s GENB Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Generate Biomedicines (GENB) in Q2 2026, closing a stake of 18,362 shares — an estimated $230K sold.

Y-Intercept (HK) first reported a position in GENB in Q1 2026 and held it in 1 quarter. The position peaked at $230K in Q1 2026. 4 funds tracked by Wall St. Rank hold GENB as of Q2 2026.

Y-Intercept (HK) reported no remaining Generate Biomedicines position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 18,362 Generate Biomedicines shares in Q2 2026, an estimated $230K.
Y-Intercept (HK) first reported a position in Generate Biomedicines in Q1 2026 and held it in 1 quarter.
Y-Intercept (HK)'s Generate Biomedicines position peaked at $230K in Q1 2026.
4 funds tracked by Wall St. Rank held Generate Biomedicines as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.